Campaign nudges US Pres Obama to add to AIDS funding, but still 'not nearly enough,' says AHF

23 August 2010

In his fiscal year 2011 budget amendments for the US Department of Health and Human Services presented for Congress consideration last Friday, President Barack Obama proposed increases for, among other things, HIV/AIDS treatment and prevention funding - possibly in response to this month's campaign by the AIDS Healthcare Foundation (AHF) advertising campaign denouncing the President for not keeping pre-election promises on funding for the condition (The Pharma Letter August 11).

The AHF's campaign - which carried the slogan 'The War on AIDS has not been won' - came on the heels of the XVIII International AIDS Conference in Vienna last month, in which President Obama received criticism for what many in the HIV/AIDS community see as a US retreat on global AIDS under his leadership. It called on President Obama to simply keep his promise on universal access to antiretrovirals by spending the $10 billion annually on global AIDS which he voted for as a Senator and committed to as a presidential candidate.

Just additional $5 million being offered

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical